Digital Marketing Trends in Inflammatory Bowel Disease
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Digital Marketing Trends in Inflammatory Bowel Disease Report Overview
AbbVie’s Skyrizi.com achieved the highest total traffic across inflammatory bowel disease (IBD) patient sites in the US, with over 9.3 million visitors from March 2022 to February 2023. This was followed by AbbVie’s Rinvoq.com and Takeda’s Entyvio.com. The highest proportion of traffic originated from direct sources, followed by organic. Xeljanz.com was supported by the most paid search engine optimization (SEO) while Takeda spent on digital display advertising (DDA) for Entyvio.com.
The digital marketing trends in the IBD report assess key digital marketing metrics of pharma assets in IBD, including branded websites for patients and healthcare professionals (HCPs), unbranded websites, and social media accounts. The report offers metrics on website traffic volume, engagement, source, digital display advertising (DDA), paid search engine optimization (SEO), and social media post interaction. Moreover, the countries analyzed in the report are the US, 4EU (Italy, France, Germany, and Spain), the UK, and Canada (EUCAN).
Major US Patient Branded Websites for Inflammatory Bowel Disease
The major US patient-branded websites for IBD are Skyrizi.com, Rinvoq.com, Entyvio.com, Humira.com, Zeposia.com, Xeljanz.com, and Stelarainfo.com. Between March 2022 and February 2023, Skyrizi.com achieved majority of the traffic and was followed by Rinvoq.com and Entyvio.com. Skyrizi.com also achieved the highest average visit duration and Humira.com had the most pages per visit and the lowest bounce rate.
Traffic Share to Branded US IBD Patient Sites, March 2022 – February 2023 (%)
For more insights into the total traffic share of the US patient-branded websites, download a free report sample
Major US HCP Branded Websites for Inflammatory Bowel Disease
The major US HCP-branded websites for IBD are Rinvoqhcp.com, Entyviohcp.com, Skyrizihcp.com, Humirapro.com, Stelarahcp.com, and Cimziahcp.com. Rinvoqhcp.com achieved most of the total traffic between March 2022 and February 2023, followed by Entyviohcp.com and Skyrizihcp.com. Humirapro.com achieved the highest average visit duration and had the highest pages per visit and lowest bounce rate.
Traffic Share to Branded US IBD HCP Sites, March 2022 – February 2023 (%)
For more insights into the total traffic share of the US HCP branded websites, download a free report sample
Top US Social Media Activity in IBD
Janssen posted the most IBD content across its social media channels. The post with the highest interaction was from its Janssen Global Instagram account, promoting its presence at UEG Week 2022. The IBD post with the highest interaction between March 2022 and February 2023 was from the Lilly Medical US Twitter account. The post promoted Lilly’s CONFIDE study in moderate-to-severe ulcerative colitis and Crohn’s disease.
Major US HCP Branded Websites for Inflammatory Bowel Disease
The major US HCP-branded websites for IBD are Rinvoqhcp.com, Entyviohcp.com, Skyrizihcp.com, Humirapro.com, Stelarahcp.com, and Cimziahcp.com. Rinvoqhcp.com achieved most of the total traffic between March 2022 and February 2023, followed by Entyviohcp.com and Skyrizihcp.com. Humirapro.com achieved the highest average visit duration and had the highest pages per visit and lowest bounce rate.
Traffic Share to Branded US IBD HCP Sites, March 2022 – February 2023 (%)
For more insights into the total traffic share of the US HCP branded websites, download a free report sample
Top EUCAN Social Media Activity in IBD
Takeda’s IBD-specific CED-trotzdem-ich.de Facebook page had the most posts. The post with the highest interaction discussed the risk of dementia with IBD. On the other hand, Galapagos’s Twitter accounts were active in posting IBD content. The highest post by interaction was from Galapagos’s German Twitter account which discussed the psychological impact of IBD.
IBD Digital Marketing Report Overview
Key US Patient-Branded Websites | Skyrizi.com, Rinvoq.com, Entyvio.com, Humira.com, Zeposia.com, Xeljanz.com, and Stelarainfo.com |
Key US HCP Branded Websites | Rinvoqhcp.com, Entyviohcp.com, Skyrizihcp.com, Humirapro.com, Stelarahcp.com, and Cimziahcp.com |
Key EUCAN Branded Websites | Abbvie-care.de, Abbviecare.fr, Abbviecare.es, Abbviecare.ca, Amgevita.ca, and Imraldi.eu |
Reasons to Buy
- Understand the digital marketing competitive landscape in IBD, to lead patient and HCP branded assets across different regions.
- See what tactics pharma companies are using to drive traffic to their IBD branded and unbranded assets for patients and HCPs, such as DDA and paid SEO.
- Understand what sources of website traffic are generating the most visits to these assets, such as paid SEO, social media, or organic searches.
- Compare top branded assets for patients by how they address and support different patient needs.
- See what pharma social media accounts in IBD are the most active and achieving the most engagement.
Janssen
Pfizer
Takeda
Bristol Myers Squibb
Eli Lilly
Galapagos
Table of Contents
Frequently asked questions
-
What are the key US patient-branded websites for Inflammatory Bowel Disease?
The key US patient-branded websites for Inflammatory Bowel Disease are Skyrizi.com, Rinvoq.com, Entyvio.com, Humira.com, Zeposia.com, Xeljanz.com, and Stelarainfo.com.
-
What are the key US HCP-branded websites for Inflammatory Bowel Disease?
The key US HCP-branded websites for Inflammatory Bowel Disease are Rinvoqhcp.com, Entyviohcp.com, Skyrizihcp.com, Humirapro.com, Stelarahcp.com, and Cimziahcp.com.
-
What are the key EUCAN-branded websites for IBD?
The key EUCAN-branded websites for IBD are Abbvie-care.de, Abbviecare.fr, Abbviecare.es, Abbviecare.ca, Amgevita.ca, and Imraldi.eu.
-
Which major US HCP branded website achieved the highest traffic for IBD between March 2022 and February 2023?
Rinvoqhcp.com achieved most of the total traffic for IBD between March 2022 and February 2023.

Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Related reports
View more Inflammatory Bowel Disease reports

